China Veterinary Medicine Market Size & Outlook, 2024-2030
China veterinary medicine market, 2018-2030 (US$M)
Related Markets
China veterinary medicine market highlights
- The China veterinary medicine market generated a revenue of USD 3,346.7 million in 2024 and is expected to reach USD 5,396.1 million by 2030.
- The China market is expected to grow at a CAGR of 8.4% from 2025 to 2030.
- In terms of segment, pharmaceuticals was the largest revenue generating product in 2024.
- Biologics is the most lucrative product segment registering the fastest growth during the forecast period.
Veterinary medicine market data book summary
| Market revenue in 2024 | USD 3,346.7 million |
| Market revenue in 2030 | USD 5,396.1 million |
| Growth rate | 8.4% (CAGR from 2025 to 2030) |
| Largest segment | Pharmaceuticals |
| Fastest growing segment | Biologics |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Biologics, Pharmaceuticals, Medicated Feed Additives |
| Key market players worldwide | Zoetis Inc Class A, Boehringer Ingelheim, Merck & Co Inc, Elanco Animal Health Inc, Dechra Pharmaceuticals, Ceva Santé Animale, Phibro Animal Health Corp Class A, Virbac SA, Bimeda Ireland, Biogenesis Bago |
Other key industry trends
- In terms of revenue, China accounted for 6.7% of the global veterinary medicine market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China veterinary medicine market is projected to lead the regional market in terms of revenue in 2030.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 3,578.8 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Veterinary Medicine Market Scope
Veterinary Medicine Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
China veterinary medicine market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to veterinary medicine market will help companies and investors design strategic landscapes.
Pharmaceuticals was the largest segment with a revenue share of 72.55% in 2024. Horizon Databook has segmented the China veterinary medicine market based on biologics, pharmaceuticals, medicated feed additives covering the revenue growth of each sub-segment from 2018 to 2030.
China's veterinary medicine market is anticipated to grow over the forecast period. The factors contributing to the market growth include growing awareness among owners and increasing animal adoption.
The surge in number of pet families in the country is accompanied by the growing demand for veterinary drugs. The need for veterinary drugs has increased significantly in recent years due to the pet industry's explosive growth, making it essential for stronger R&D efforts.
In May 2022, the criteria for clinical authorization of veterinary biological products were prioritized and streamlined. The minimum requirement for the number of animals used in clinical trials to develop veterinary biological products was decreased from at least 200 animals to at least 50 animals.
Reasons to subscribe to China veterinary medicine market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of China veterinary medicine market databook
-
Our clientele includes a mix of veterinary medicine market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the China veterinary medicine market , including forecasts for subscribers. This country databook contains high-level insights into China veterinary medicine market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
China veterinary medicine market size, by product, 2018-2030 (US$M)
China Veterinary Medicine Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
